Contact Us
Drug Search Results
More Filters [+]

AZD-6615

Alternative Names: azd-6615, azd 6615, azd6615
Latest Update: 2020-12-14
Latest Update Note: Clinical Trial Update

Product Description

AstraZeneca is developing AZD-6615 as a treatment for Dyslipidemia. (Sourced from: https://classic.clinicaltrials.gov/ct2/show/NCT04055168)

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: N/A

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: AstraZeneca
Company Location: CAMBRIDGE X0 CB2 0AA
Company CEO: Pascal Soriot
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for AZD-6615

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 1: Dyslipidemia

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
D7991C00001

P1

Terminated

Dyslipidemia

2020-02-10

59%

Recent News Events

Date

Type

Title

11/13/2020

News Article

 Promising new data for Ionis' antisense medicine targeting PCSK9 presented at American Heart Association (AHA) Scientific Sessions 2020

11/12/2020

News Article

 Ionis' pioneering antisense technology to be featured in multiple presentations at American Heart Association (AHA) Scientific Sessions 2020

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions